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Abstract
The prevalence of antimicrobial resistance (AMR) varies significantly among different patient
populations. We aimed to summarise AMR prevalence data from screening studies in different
patient settings in Switzerland and to identify surveillance gaps.We performeda systematic review,
searching Pubmed,MEDLINE, Embase (01/2000–05/2017) and conference proceedings for Swiss
studies reporting on carbapenemase-producing Enterobacteriaceae (CPE), extended-spectrum
beta-lactamases (ESBL), mobilised colistin-resistance, methicillin-resistant Staphylococcus aureus
(MRSA) and vancomycin-resistant Enterococci (VRE) within different patient settings. We iden-
tified 2345 references and included 46 studies. For acute care patients, most screening data
come from admission screenings, whereas AMR prevalence among hospitalised patients is
largely unknown. Universal admission screenings showed ESBL-prevalences of 5–8% and
MRSA-prevalences of 2–5%. For targeted screening, ESBL-prevalence ranged from 14–21%;
MRSA-prevalence from 1–4%. For refugees, high ESBL (9–24%) and MRSA (16–24%) car-
riage rates were reported; returning travellers were frequently (68–80%) colonised with
ESBL. Screening data for other pathogens, long-term care facility (LTCF) residents and pediatric
populations were scarce. This review confirms high ESBL- and MRSA-carriage rates for risk
populations in Switzerland. Emerging pathogens (CPE andVRE) and certain populations (inpa-
tients, LTCF residents and children) are understudied.We encourage epidemiologists and public
health authorities to consider these findings in the planning of future surveillance studies.
Introduction
According to the World Health Organisation antimicrobial resistance (AMR) is one of the
most concerning threats to modern medicine [1]. Surveillance has been formulated by the
Centers for Disease Control and Prevention (CDC) as one of the four core actions among pub-
lic health strategies against AMR [2]. Both national and international AMR surveillance pro-
grams are mainly based on phenotypic resistance data of bacterial isolates from clinical
routine, without detailed information on patient characteristics or patient setting [3, 4].
However, AMR prevalence varies considerably between different patient populations, a fact
which is not adequately represented in current surveillance systems. Examples for high-risk
populations include patients transferred from abroad or residents of long-term care facilities
(LTCF) [5, 6]. These high-risk groups could potentially act as reservoir for the distribution
and spread of AMR within healthcare networks [7].
Knowing the prevalence of AMR among these populations might not only aid clinicians in
their choice of empirical antibiotic treatment, but also support infection control specialists in
prioritising prevention measures or guide public health authorities in planning future screen-
ing studies. In this systematic review, we aimed to summarise patient screening data for the
most important antibiotic resistant pathogens within different patient settings in
Switzerland, to identify screening gaps and to interpret these findings in the context of resist-
ance data from neighbouring countries.
Methods
Aims
The primary study aims were (i) to summarise prevalence data on antibiotic resistance from
studies performed in different patient settings in Switzerland between the year 2000 and
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2017 and (ii) to identify gaps in surveillance for important patient
populations. We focussed on studies reporting on carbapenemase-
producing Enterobacteriaceae (CPE), extended-spectrum
β-lactamase (ESBL)-producing or extended-spectrum cephalo-
sporin resistant (ESC-R) Enterobacteriaceae, pathogens harbouring
the mobilised colistin resistance (MCR)-gene, methicillin-resistant
Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci
(VRE). These five resistant pathogen groups (subsequently simply
calledpathogens)– accounting for almost two thirds of deaths caused
by AMR in the US – were chosen based on their presumed import-
ance for Switzerland [2].
The following settings are defined: acute/intensive care (i.e.
universal and targeted admission screenings, other screenings),
outpatients, LTCF and specific risk groups (i.e. refugees, travellers,
people in contact with livestock, intravenous drug users [IVDU]
and others). Studies in the paediatric population were analysed
separately. This study is being reported according to the
PRISMA guidelines [8].
Design and study criteria
We performed a systematic literature search for studies meeting
all of the following inclusion criteria: (i) studies (i.e. point-
prevalence, cross-sectional and interventional studies, admission
screenings, cohort and case-control studies) reporting prevalence
data among specific patient populations; (ii) studies performed in
Switzerland and (iii) majority of data collected after 1999. Studies
on patients of all ages colonised with any of the five pathogen
groups of interest at any body site (i.e. any screening method)
were included.
The following exclusion criteria were applied: studies not
including prevalence data (e.g. comments, reviews or editorials,
case reports or outbreak reports without additional screenings);
studies reporting AMR prevalence among clinical isolates but
not among patients; studies focussing on animal or environmental
samples; studies reporting only data on molecular epidemiology
and studies including data from other countries, where the
Swiss data were not presented separately.
The following microbiologic definitions had to be met:
• CPE: any Enterobacteriaceae with detection of a carbapenemase
gene
• ESBL/ESC-R: any Enterobacteriaceae with non-susceptibility to
a 3rd/4th-generation cephalosporine OR detection of an ESBL
gene by polymerase chain reaction
• MCR: any pathogen with detection of a mcr-gene
• MRSA: S. aureus with non-susceptibility to oxacillin OR detec-
tion of mecA gene
• VRE: any Enterococcus faecalis/faecium with non-susceptibility
to vancomycin OR documentation of vanA, vanB or vanC
positivity
Search methods
A professional librarian performed a literature search in the
Pubmed, MEDLINE and Embase databases (from 1 January
2000 to 5 May 2017). We used both medical subject headings
and text word terms for AMR or each of the five key pathogens
AND Switzerland (Supplements Table S1). Furthermore, conference
proceedings of the European Congress of Clinical Microbiology and
Infectious Diseases (ECCMID), 2015 to 2017, and the Joint Annual
Meeting of the Swiss Society for Infectious Diseases (SSI), 2013–
2017, were screened. Bibliographies of included records were
screened for relevant articles. No language restrictions were applied.
Studies which met inclusion criteria underwent full-text review.
Abstract screening and full-text review were performed by two inde-
pendent reviewers. Reviewers were not blinded for author names,
institution names or the journal name.
Data extraction and management
The following data are abstracted from the selected studies: study
design, study year(s), geographic location within Switzerland
(French vs. German vs. Italian speaking regions), patient setting
(see above), additional particular patient characteristics (if any),
type of antibiotic resistance including resistance mechanism (if
available) and screening sites. Every study was assigned a time
period (i.e. 2000–2005; 2006–2011; 2012–2016), depending on
when the majority of the study data were generated. All data
were double entered by two independent reviewers and any dis-
crepancies were resolved by consensus. Because of presumed het-
erogeneity between studies, no pooled prevalence estimate was
calculated. Prevalence data were plotted by type of pathogen
and study setting (this analysis was only performed for CPE,
ESBL and MRSA because of the small number of studies for
MCR-producers and VRE).
Results
We identified a total of 791 unique references and 1554 confer-
ence abstracts. One-hundred and eighteen records underwent
full-text review and 46 records, thereof eight conference abstracts,
were included in our review (Fig. 1). A descriptive summary of the
available literature by patient setting is given below. Details of
included studies, separated by Gram-negative and Gram-positive
pathogens, are presented in Tables 1 and 2. For identification of
surveillance gaps, studies are plotted in Figure 2, stratified by
pathogen, patient setting and time period.
Acute care
Universal screenings
Data from universal hospital admission screenings (i.e. screening of
all patients upon hospital admission) are available for ESBL and
MRSA. For ESBL, prevalences of 5% (2010) and 8% (2014/2015)
have been reported [9, 10]. For MRSA, several older studies from
the Geneva University Hospital showed prevalences of 3% (2003,
mixed population) [11], 5% (2004–2006, surgical patients) [12]
and 2% (2010, internal medicine) [13]. In the study from 2003,
13 of 428 MRSA isolates were classified as community-acquired
(CA)-MRSA, thereof fivewith production of Panton-Valentine leu-
kocidin (PVL) [11]. No data are available for other pathogens.
Targeted admission screenings
Targeted screenings (i.e. screening of high-risk patients upon
admission, mostly those transferred from abroad) have shown
low CPE prevalences between 1% (2012/2013) and 3% (2013–
2016) [14, 15]. For ESBL, these numbers have ranged between
14% and 21% [14–18]. For MRSA, targeted screenings performed
in the German-speaking part revealed low prevalence rates
between 1% and 3% [14, 18–20].
Other screening studies
One study from 2005/2006 screened patients before colorectal
surgery, whereof 9% were MRSA positive [21]. Another study
found a MRSA prevalence of 7% among all discharged patients
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Fig. 1. Results of literature search and flow-diagram.
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Table 1. Prevalence of antibiotic resistant Gram-negative pathogens among different patient populations in Switzerland
Author Years Setting Comment Study type Region Screening Pathogens/mechanism Prev Number
CPE
Kaspar [14] 2012/13 Acute care Targeted: Hospitalisation abroad Admission scr East/Cent N, I, R/S, Oth 0.9 2/235
Lemmenmeier [15] 2013–16 Acute care Targeted: Hospitalisation abroad Admission scr East/Cent R, Oth 3.2 7/217
Nüesch [39] 2012 Outpatients GP pts Cross sectional Mixed/unk S 0 0/291
Joao [29] 2015/16 Outpatients HIV-infected pts Cross sectional Mixed/unk S 0 0/101
Kuenzli [34] 2012/13 Other Traveller to South Asia Cohort East/Cent R E. coli NDM-1 0.6 1/170
Zurfluh [38] 2014 Other Meat processing company workers Cross sectional Mixed/unk S OXA-48 0.1 1/1086
Nüesch [39] 2012 Other Meat processing company workers Cross sectional Mixed/unk S 0 0/314
Erb [16] 2011–16 Other Refugees Admission scr East/Cent Unk 0 0/119
Piso [45] 2015 Other Refugees Cross sectional Mixed/unk R, U 0 0/241
Kraemer [41] 2015 Other Pig farmers Cross sectional Mixed/unk S 0 0/25
Moulin [51] 2016 Ped (in) Neonatal ICU Outbreak West S K. pneumoniae OXA-48 1.9 2/108
ESBL or resistance to extended-spectrum cephalosporins
Martinez [9] 2014–15 Acute care Universal: medical/surgical ICU Admission scr East/Cent R 7.9 24/302
Pasricha [10] 2010 Acute care Universal Admission scr West R 76% E. coli 4.8 51/1072
Nemeth [18] 2009–11 Acute care Targeted: Hospitalisation abroad Admission scr East/Cent N, P, I, Oth 13.9 36/259
Kaspar [14] 2012/13 Acute care Targeted: Hospitalisation abroad Admission scr East/Cent N, I, R/S, Oth 17.0 40/235
Lemmenmeier [15] 2013–16 Acute care Targeted: Hospitalisation abroad Admission scr East/Cent R, Oth 15.2 33/217
Fankhauser [17] 2006 Mixed Targeted: Hospitalisation abroad Admission scr West R Enterobacteriaceae 18.0 22/124
Nüesch [28] 2012 Outpatients GP pts Cross sectional East/Cent S Mostly E. coli, CTX-M 5.2 15/291
Joao [29] 2015/16 Outpatients HIV-infected pts Cross sectional Mixed/unk S E. coli, mostly CTX-M-15 6.9 7/101
Vuichard [49] 2014–16 Other Pregnant women Cross sectional East/Cent R, V E. coli 3.2 6/190
Geser [40] 2010 Other Meat processing company workers Cross sectional Mixed/unk S E. coli, mostly CTX-M 5.8 34/586
Kraemer [41] 2015 Other Pig farmers Cross sectional Mixed/unk S E. coli, CTX-M 12.0 3/25
Kuenzli [36] 2015 Other Pre-Travel South-East Asia Cohort Mixed/unk Unk 0 0/147
Bernasconi [35] 2015 Other Pre-Travel India Cross sectional Mixed/unk S E. coli 7.9 3/38
Pires [37] 2014/15 Other Pre-Travel India Cohort Mixed/unk S 10.0 4/40
Uckay [50] 2009–11 Other HCW on orthopedic wards Cohort West R 12.2 6/41
Erb [16] 2011–16 Other Refugees Cross sectional East/Cent Unk 9.2 11/119
Piso [45] 2015 Other Refugees Cross sectional Mixed/unk R, U E. coli 23.7 57/241
Kuenzli [34] 2012/13 Other Post-Travel South-East Asia Cohort East/Cent R Mostly E. coli 69.4 118/170
Pires [37] 2014/15 Other Post-Travel India Cohort Mixed/unk S 76.0 31/40
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from a tertiary care hospital [22]. Both studies were performed in
the Western part of Switzerland. Two more recent studies from
the German part, evaluating MRSA prevalence among hospita-
lised contacts of known MRSA carriers, showed prevalence rates
of only 0.4% (2008–2014) and 1.3% (2009) [23, 24].
Long-term care facilities/geriatric hospitals
For CPE or ESBL-producers, no screening data are available from
LTCFs. For MRSA, prevalence in geriatric patients upon hospital
admission was reported to be 8% in 2001/2003 [25]. Screening of
nursing home residents in 2010/11 showed a similar prevalence of
9%, with a decreasing trend over time (5% in a follow-up study
from 2015) [26, 27]. All these studies were performed in the
French speaking part of Switzerland.
Outpatients
No CPE carriers were detected in two cross-sectional studies
among primary care (2012) and HIV-infected patients (2016)
[28, 29]. The same studies also assessed ESBL carriage, showing
a prevalence of 5% and 7% [28, 29]. Two cross-sectional studies
looked at MCR prevalence among outpatients. Whereas the one
study among HIV patients found 1% to be colonised with an
MCR-1 producing E. coli [29], the other study did not identify
any cases [30]. Other screening studies among outpatients have
shown MRSA prevalence rates of 0% (pregnant women from for-
mer Yugoslavia), 1% (dental care patients) and 2% (patients with
skin infections) [31–33].
Other specific risk groups
Returning travellers
Screening for CPE identified only 1 carrier of NDM-1 E. coli
(0.6%) among returning travellers from South Asia (2012/2013)
[34]. ESBL-carriage was much more common and ranged
between 68 and 80% (2012–2015) [34–37]. For MCR, 1 out of
38 (3%) travellers to India was found to have acquired an
MCR-1 harbouring E. coli during travel [35].
People in contact with livestock
A dedicated group of Swiss investigators has studied the presence of
resistant pathogens among workers of a meat processing factory. In
one study, one out of more than 1000 (0.1%) workers was colonised
with an OXA-48-producing E. coli (2014), whereas no CPE were
detected in a similar study 2 years earlier [38, 39]. For ESBL, preva-
lence was 6% in the same population (2010) [40]; a study from 2016
regarding colonisation with MCR-producers revealed no positive
sample [30]. Among pig farmers, no CPE were detected in 2015
whereas ESBL-prevalence was relatively high at 12% [41]. MRSA
prevalence among pig farmers was 6.6% in 2008 [42], 0% in
2009 [43] and 12% in 2015 [41]. No MRSA was detected among
slaughterhouse workers (2009), whereas 3% and 4% of screened
veterinarians were MRSA-positive (2009 and 2012) [42–44].
Refugees
Two studies have assessed carriage of resistant pathogens among
refugees. One study which screened asylum seekers presenting at a
tertiary care hospital (2014/2015) showed an MRSA-prevalence of
21%, whereas ESBL- and CPE-prevalence was 9% and 0%,
respectively [16]. Another cross-sectional study (2015) performed
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Table 2. Prevalence of antibiotic resistant Gram-positive pathogens among different patient populations in Switzerland
Author Years Setting Comment Study type Region
Screening
site(s) Prev Number
MRSA
Harbarth [12] 2004–06 Acute care Universal: 94% of all
surgical pts
Admission
scr
West N, R, Oth 5.1 515/10
193
Pasricha [13] 2010 Acute care Universal: 86% of
internal medicine pts
Admission
scr
West N, I 2.4 41/1740
Witteck [19] 2008–09 Acute care Targeted: High risk pts Admission
scr
East/Cent N, P, A/I, Oth 3.7 6/161
Nemeth [18] 2009–11 Acute care Targeted:
Hospitalisation abroad
Admission
scr
East/Cent N, P, I, Oth 1.2 3/259
Kaspar [14] 2012/13 Acute care Targeted:
Hospitalisation abroad
Admission
scr
East/Cent N, I, R/S,
Oth
1.7 4/235
Harbarth [11] 2003 Mixed Universal: focus on
CA-MRSA
Admission
scr
West N, I, Oth 3.0 428/14
253
Huttner [21] 2005–06 Acute care Pts 30 days before
colorectal resection
Cohort West N, R, Oth 9.3 18/194
Landelle [22] 2007 Acute care All patients Discharge
scr
West N, I 7.8 70/898
Buhlmann [20] 2005–06 Acute care Patients at risk including
admission scr
Other East/Cent N, I, Oth 1.7 4/232
Bächli [23] 2008–14 Acute care Contacts of MRSA pts Other East/Cent Unk 0.4 12/3013
Valsesia [24] 2009 Acute care Contacts of MRSA pts Other East/Cent N 1.3 1/80
Sax [25] 2001/03 LTCF Universal scr Admission
scr
West N, R, Oth 8.1 131/
1621
Bellini [26] 2010/11 LTCF Pts from 104 different
nursing homes
RCT West N, I, Oth 8.9 366/
4108
Héquet [27] 2015 LTCF Pts from 33 different
nursing homes
Cross
sectional
West N, P, I 4.7 54/1150
Marschall [31] 2004–05 Outpatients Pregnant women from
Ex-Yugoslavia
Cross
sectional
East/Cent N, V 0 0/152
Zimmerli [32] 2006 Outpatients Dentist pts colonised
with S. aureus
Cross
sectional
East/Cent N, P 1.0 2/210
Fleisch [46] 2002 Other IVDU Cross
sectional
East/Cent N 10.3 23/224
Fleisch [48] 2005 Other IVDU Cross
sectional
East/Cent N 5.4 6/111
Colombo [47] 2008–09 Other IVDU Cross
sectional
East/Cent N, P, Oth 1.0 5/497
Fleisch [48] 2002 Other Healthcare workers in
care of IVDU
Cross
sectional
East/Cent N 0 0/80
Valsesia [24] 2009 Other Healthcare workers in
care of MRSA pts
Other East/Cent N 0 0/202
Huber [43] 2009 Other Slaughterhouse workers Cross
sectional
Mixed/unk N 0 0/179
Huber [43] 2009 Other Veterinarians Cross
sectional
Mixed/unk N 3.0 4/133
Wettstein [44] 2012 Other Veterinarians Cross
sectional
Mixed/unk N 4.1 14/340
Piso [45] 2015 Other Refugees Mixed Mixed/unk N, P, I 15.7 41/261
Erb [16] 2011–16 Other Refugees Admission
scr
East/Cent Unk 21.0 25/119
Oppliger [42] 2008–09 Other Pig farmers/
veterinarians
Cross
sectional
West N 6.7 5/75
(Continued )
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in four refugee centres found a MRSA-prevalence of 16%,
ESBL-prevalence of 24% and again no CPE carriers [45].
Intravenous drug users
Several studies have looked at MRSA prevalence among IVDU.
Whereas prevalence was as high as 10% around the year 2000
[46], the number dropped to 5.4% in 2005 and to 1% in 2008/
2009 [47, 48].
Other adult populations
For ESBL, prevalence varies greatly by risk population: 3% (6/190)
in pregnant women [49]; 0–10% in individuals before travel [35–37]
and 12% among health-care workers [50]. The MRSA prevalence
rate among healthcare workers in charge of MRSA patients was
0% (2002 and 2009) [24, 48].
Pediatric population
During an outbreak of ESBL-producing Klebsiella pneumoniae in
a neonatal intensive care unit 108 patients were screened, whereof
six were positive. Unexpectedly, 2% were also positive for OXA-48
producing K. pneumoniae [51]. For MRSA, admission screening
of high-risk patients found prevalence rates of 0.1% (2006) and
0% (2014/2015) [52, 53]. Another study from 2009 screening hos-
pitalised contacts of pediatric MRSA patients confirmed this very
low prevalence [24].
Discussion
We comprehensively summarised the available literature on AMR
screening data with regard to different patient settings in
Switzerland. Data in this review confirm the high prevalence of
ESBL among patients transferred from abroad and returning tra-
vellers; refugees are at high risk for both ESBL- and
MRSA-carriage. In general, little information is available from
LTCFs and the pediatric population; prevalence data on emerging
pathogens such as CPE and VRE are scarce.
AMR is primarily a concern in acute and intensive care patients
due to severe underlying illnesses, antibiotic pre-treatment and
medical interventions predisposing for hospital-acquired infections
[54–57]. According to a nation-wide survey in Swiss healthcare
facilities, 83% of institutions are currently performing targeted
admission screenings for multidrug-resistant pathogens.
Considerable heterogeneity exists regarding target populations
and screening methods [58]. Data from targeted admission
screenings in Switzerland are comparable to numbers in
Germany, where similar carriage rates among patients transferred
from abroad for resistant Gram-negatives (13% vs. 14–17% in our
review) and for MRSA (4% vs. 1–4% in our review) were found
[6]. ESBL-prevalence from universal admission screening was
8% in a study included in our review, which is comparable to
the 10% prevalence found in a German study [9, 59]. One of
the most urgent antibiotic resistant threats, coming along with
increased morbidity and mortality in infected patients, are CPE
[60]. Looking at neighbouring countries, CPE prevalence in
acute care settings varies considerably. Prevalence was reported
to be as low as 0.1% upon hospital admission in Germany [61]
and 0.4% among hospitalised acute care patients in southern
France in 2012 [62]. In Italy, 8% of clinical Enterobacteriaceae iso-
lates from inpatients were carbapenem-resistant in 2013 [63]. In
Switzerland, according to national laboratory-based surveillance
data, absolute numbers of CPE have been increasing in recent
years, with OXA-48 being the most commonly reported carbape-
nemase followed by K. pneumoniae carbapenemase [64]. The fact
that only 64% of Swiss healthcare institutions are actually per-
forming targeted CPE admission screenings is worrisome [58].
Except from admission screenings, no prevalence data exist
from Swiss acute care hospitals for these primarily nosocomial
pathogens. However, modelling studies for the English hospital
networks have shown that, because of the high number of patient
transfers within the own healthcare network, the absolute risk of
CPE introduction is higher for patients transferred within than
those transferred from outside these networks, even if the local
CPE prevalence is low [65]. In accordance with the conclusions
drawn by the authors of this study, we think that further studies
are needed to evaluate if CPE emergence in Switzerland is merely
due to an increase of imported cases or if patients are increasingly
acquiring CPE in Swiss hospitals. Regarding VRE, no screening
studies have been published until date of this literature search.
Of note, VRE have lately become a pressing issue in
Table 2. (Continued.)
Author Years Setting Comment Study type Region Screening
site(s)
Prev Number
Huber [43] 2009 Other Pig farmers Cross
sectional
Mixed/unk N 0 0/148
Kraemer [41] 2015 Other Pig farmers Cross
sectional
Mixed/unk N 12.0 3/25
Heininger [52] 2006 Ped (in) All patients Admission
scr
Mixed/unk N 0.1 1/1337
Johnson [53] 2014/15 Ped (in) Universal scr (64%) of all
pediatric pts
Admission
scr
East/Cent N 0 0/340
Valsesia [24] 2009 Ped (in) Contacts of MRSA pts Other East/Cent N 0 0/10
VRE
Voide [88] 2010–11 Outpatients Pts hospitalised during
VRE outbreak
Discharge
scr
West R 0 0/203
Prev, prevalence (in %); Pt, patient; N, nasal; P, pharyngeal or throat; A, axillary; I, inguinal or groin; S, stool or faecal; R, rectal or perineal; U, urine; V, vaginal, Oth, others sites (depending on
clinical picture); Unk, unknown; Ped (in), pediatric inpatients; Scr, screening; Cent, central; LTCF, long-term care facility; CA, community-acquired; IVDU, intravenous drug users; RCT,
randomised controlled trial.
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Switzerland, with multiple outbreaks having been reported within
and between healthcare facilities [66, 67]. It remains to be seen if
VRE will become endemic in this patient setting as it has for cer-
tain regions in Germany [68].
An important finding of our review is the scarcity of resistance
data from Swiss LTCFs. This is concerning, because (i) LTCFs
have been recognised as highly endemic settings for resistant
pathogens already more than two decades ago [5, 69] and (ii) a
recent laboratory-based study from Swiss LTCFs showed a clear
increase in E. coli isolates resistant to extended-spectrum cepha-
losporins over the last decade [70]. Looking at neighbouring
countries, data from LTCFs in Italy show that the prevalence of
ESBL-producers and CPE is as high as 64% and 6%, respectively
[71, 72]. A point prevalence study from 2015 performed in an
Austrian LTCF reported a prevalence of 13% for ESBL, whereas
no CPE were found [73]. In Germany, data from 2012 among
nursing home residents showed a prevalence of 27% for ESBL,
9% for MRSA and 3% for VRE [74]. Only a minority of hospitals
in Switzerland are routinely screening patients residing in LTCFs
upon hospital admission [58]. Whether this strategy misses a rele-
vant number of patients carrying resistant pathogens is currently
unknown.
Similar to our data, a recently published review on AMR among
European migrants found a high prevalence of MRSA (8%) and
resistant Gram-negative bacteria (27%), concluding that living con-
ditions, access to healthcare and AMR detection should be
improved in this high-risk population [75]. In line with our find-
ings, data from Germany suggest that ESBL-colonisation seems to
be common among refugees, whereas CPE are rarely detected
[76]. Data from other countries as well as a recent review confirm
Fig. 2. Prevalence data per patient setting and time period in Switzerland for ESBL, CPE and MRSA. Every circle represents a single study; circle diameter correlates
with the study sample size. Please note the different scaling of the y-axis for the CPE, ESBL and MRSA. Acute/intensive care (UnivScr, Universal admission screening;
TargScr, Targeted admission screening; OthAcute, Other inpatients); LTCF, Long-term care facility; Outpat, Outpatients; Ped, Paediatric patients; other risk popula-
tions (Refug, Refugees; Trav, Returning travellers; Livestock, people working in livestock industry; IVDU, Intravenous Drug Users).
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the high prevalence of particularly resistant Gram-negative patho-
gens among returning travellers [77–80]. None of the studies in
our review performedMRSA screening among returning travellers.
However, a multicentre study from different European cities –
including a Swiss study centre – reported an MRSA prevalence of
14% (2019) among returning travellers with skin and soft tissue
infections, with Latin America as travel destination being a risk
factor for MRSA carriage. A large proportion of these isolates
were PVL-producing CA-MRSA [81]. Interestingly, although
MRSA rates are generally decreasing in Switzerland [82], the
prevalence among pig farmers – who are likely to be colonised
with livestock-associated MRSA – has increased between 2009
and 2015. This finding is in line with reports from Germany,
showing increasing trends for LA-MRSA while overall MRSA
rates are declining [83, 84]. Until now, CPE and MCR are not
commonly detected in these settings in Switzerland. Again, no
data exist for VRE.
Studies on AMR screening from the pediatric population are
rare in Switzerland. National laboratory-based surveillance data
suggest that the prevalence of ESBL and MRSA among clinical
isolates is similar to that of the adult population [82, 85, 86].
Of note, the unexpected finding of two neonates carrying
OXA-48-producing K. pneumoniae in Switzerland is worrying
and warrants further study [51]. Similar to adult refugees, pediat-
ric refugees are at particular risk of carrying resistant pathogens,
as shown recently in two German studies [76, 87].
Our study has some limitations. First, the heterogeneity among
included studies (e.g. definitions of risk for targeted admission
screenings, different screening sites) precluded us from calculating
a pooled prevalence or from statistically assessing trends over time.
In this context it is particularly important to note that clinical micro-
biology breakpoints have changed during the observed time period.
Second, although we performed a thorough literature search we
might havemissed studies, especially those onlypresented as abstracts
in conferences which were not on our screening list. Third, some of
the most recent publications were only available in an abstract
form.Nonetheless, we included these studies as wewould have other-
wise missed the most recent data in this rapidly changing field.
In conclusion, this review confirms data from other countries
showing high prevalence of ESBL-carriage among patients trans-
ferred from abroad and returning travellers; refugees are at risk
for both ESBL and MRSA. There is a scarcity of AMR prevalence
data from Swiss LTCFs and the pediatric population. Also, screen-
ing data are generally scarce for emerging pathogens such as CPE or
VRE, which often spread within and between acute care facilities.
We encourage epidemiologists and public health authorities to con-
sider these gaps in the planning of future surveillance studies.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0950268819001523.
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